34thAnnual
Feldman Lecture

 

PHILIP COWEN, BSc, MB, BS, MD, FRCPsych

Psychopharmacology University of Oxford

Professor Philip (Phil) Cowen, BSc, MB, BS, MD, FRCPsych, is a British psychiatrist and psychopharmacologist. He is Professor of Psychopharmacology at the University of Oxford, and honorary consultant psychiatrist at Oxford Health NHS Foundation Trust. He is recognized internationally for his outstanding research into mood disorders and their treatment, and has also made major contributions to psychopharmacology via teaching, clinical practice, and treatment guideline development.

Phil trained in medicine at University College Hospital, London, and then in psychiatry at King’s College Hospital. He moved to Oxford in 1979 to work in the MRC Unit of Clinical Pharmacology under Professor David Grahame-Smith. His achievements and potential were recognized in 1983 when he was appointed a Medical Research Council Clinical Scientist, a post which he still holds today – the only psychiatrist to do so and testimony to the sustained excellence and productivity of his research. He was elected to a personal chair in Psychopharmacology at the University of Oxford in 1997. He has been honored with many awards, including a NARSAD Distinguished Investigator Award (2000), election to Fellowships of the Academy of Medical Sciences (2001) and a Lifetime Achievement Award from the British Association of Psychopharmacology in 2014.

  • May 2017
    Registration Opens. Early bird fee $175.00; Students $100.
  • Sept. 1, 2017
    Registration fee increases to $200.00; registrations become non-refundable.
  • October 20, 2017
    Conference
 
This Grey Nuns Hospital Grand Rounds event is approved for 5 hours as an Accredited Group Learning Activity under Section 1 of the Framework of CPD options for the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
 

Phil’s academic focus has been on the neurobiology and psychopharmacology of mood disorders, especially unipolar depression. He is perhaps best known for his many studies on the contribution of the serotonin, but his research has extended to a range of other topics including emotional processing, glutamate, and inflammation, and encompasses many approaches, from functional imaging to clinical trials. Highlights of his research include:

  • Discovering inverse agonism at the benzodiazepine receptor (with David Nutt and Hilary Little)
  • Showing that tryptophan depletion causes a rapid relapse of depressive symptoms
  • Demonstrating that dieting affects 5-HT functioning, and that this may contribute to the onset of eating disorders after dieting (with Chris Fairburn and Guy Goodwin)
  • Using PET to show down-regulation of 5-HT1A receptors in depression, and its persistence after recovery (with Paul Grasby)
  • Demonstrating (with Catherine Harmer and Guy Goodwin) that antidepressants alter emotional processing, leading to a new Cognitive-psychopharmacological model, which has transformed understanding of how antidepressants work.
  • Phil has published over 500 scientific papers, many in leading journals such as Nature, The Lancet, Archives of General Psychiatry and the American Journal of Psychiatry. His h-index is 85.
  • Phil has been senior author of the past two editions of the Shorter Oxford Textbook of Psychiatry.

Phil's current work focuses on the development and repurposing of novel pharmacological agents with the aim of improving current treatments. He is particularly interested in the anti-oxidant drug, ebselen, as a possible lithium-mimetic in patients with bipolar disorder, and the use of selective serotonin receptor ligands as potential antidepressants. He continues to work clinically in patients with refractory mood disorders and has emphasized the value of long-term clinical relationships in the treatment of patients with these burdensome conditions.

Agenda

Auditorium, Grey Nuns Community HospitalOctober 20, 2017
7:30 AM

Registration / Breakfast

8:30 AM

Introductions – Dr. Jan Banasch

9:00 AM

Lecture 1: Classification of Depression & Implications for Treatment

10:15 AM

Coffee Break

10:45 AM

Lecture 2: Serotonin, Depression & Antidepressants

12:00 PM

Lunch

1:00 PM

Lecture 3: Pharmacological Treatment of Depression: Where have we come from & Where are we Going?

2:15 PM

Question & Answer "Meet the Professor"

Contact & Registration

1100 Youville Drive West Northwest Edmonton, AB T6L 5X8

For further information, contact:

Sharon Reimer at 780-735-7145 or
email Sharon.Reimer@covenanthealth.ca

Please note: No refunds after September 1, 2017.

 

History of the Feldman Lecture - 1983-2016

2016

David Nutt, M.D.

2015

Jeffrey Lieberman, M.D.

2014

Kay Redfield Jamison

2013

Baroness Susan Greenfield

2012

Stephen Michael Stahl, M.D., Ph.D.

2011

Dr. Arya Sharma

2010

Dr. Martin Seligman

2009

Dr. Kenneth Kendler

2008

Arthur Caplan, PhD

2007

Christine A. Padesky, PhD

2006

Dr. John W. Newcomer

2005

Lt.-Gen. Romeo Dallaire

2004

Dr. Roger D. Weiss

2002

Dr. Shitij Kapur

2001

Dr. Harold Sackheim

2000

Dr. Heidi L. Heard

1999

Dr. Michael F. Myers

1998

Dr. Glen Gabbard

1997

Dr. Norman Sartorius

1996

Dr. Philip Seeman

1995

Dr. Sheldon Preskorn

1994

Dr. Robert M. Post

1993

Dr. C.B. Nemeroff

1992

Dr. Bessel A. van der Kolk

1991

Dr. Marie Asberg

1990

Norman E. Rosenthal, M.D.

1989

Professor Sir Martin Roth

1988

Dr. Harold Mersky

1987

Cancelled

1986

Dr. Hagop S. Akiskal, M.D.

1985

Dr. David Sheehan

1984

Dr. Heinz Lehmann

1983

Dr. Paul E. Garfinkel, M.D., F.R.C.P. (C)